Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50% - 16/08/24
Résumé |
Background |
The Seattle Proportional Risk Model (SPRM) estimates the proportion of sudden cardiac death (SCD) in heart failure (HF) patients, identifying those most likely to benefit from implantable cardioverter-defibrillator (ICD) therapy (those with ≥50% estimated proportion of SCD). The GISSI-HF trial tested fish oil and rosuvastatin in HF patients. We used the SPRM to evaluate its accuracy in this cohort in predicting potential ICD benefit in patients with EF ≤50% and an SPRM-predicted proportion of SCD either ≥50% or <50%.
Methods |
The SPRM was estimated in patients with EF ≤50% and in a logistic regression model comparing SCD with non-SCD.
Results |
We evaluated 6,750 patients with EF ≤50%. There were 1,892 all-cause deaths, including 610 SCDs. Fifty percent of EF ≤35% patients and 43% with EF 36% to 50% had an SPRM of ≥50%. The SPRM (OR: 1.92, P < 0.0001) accurately predicted the risk of SCD vs non-SCD with an estimated proportion of SCD of 44% vs the observed proportion of 41% at 1 year.
By traditional criteria for ICD implantation (EF ≤35%, NYHA class II or III), 64.5% of GISSI-HF patients would be eligible, with an estimated ICD benefit of 0.81. By SPRM >50%, 47.8% may be eligible, including 30.2% with EF >35%. GISSI-HF participants with EF ≤35% with SPRM ≥50% had an estimated ICD HR of 0.64, comparable to patients with EF 36% to 50% with SPRM ≥50% (HR: 0.65).
Conclusions |
The SPRM discriminated SCD vs non-SCD in GISSI-HF, both in patients with EF ≤35% and with EF 36% to 50%. The comparable estimated ICD benefit in patients with EF ≤35% and EF 36% to 50% supports the use of a proportional risk model for shared decision making with patients being considered for primary prevention ICD therapy.
Le texte complet de cet article est disponible en PDF.Plan
| The Seattle Proportional Risk Model (SPRM) predicts that only half of patients in the GISSI-HF registry that meet current guidelines derive a meaningful benefit from ICD implantation, and that 43% of patients with an ejection fraction ranging from 36% to 50% would benefit from an ICD. #SPRM #SHFM #SCD |
Vol 275
P. 35-44 - septembre 2024 Retour au numéro
Article précédent
- Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
- Jonathan Kusner, Ravi B. Patel, Mo Hu, Alain G. Bertoni, Erin D. Michos, Ambarish Pandey, Lisa B. VanWagner, Sanjiv Shah, Marat Fudim
- The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery
- Flavia K. Borges, Daniel I. Sessler, Maria Tiboni, Ameen Patel, Yannick LeManach, Diane Heels-Ansdell, Sadeesh Srinathan, Chew Yin Wang, Clara Chow, Emmanuelle Duceppe, Peter Kavsak, Sandra N. Ofori, Shirley Pettit, Otavio Berwanger, Andrea Kurz, Alparslan Turan, Ana Claudia Tonelli, PJ Devereaux, VISION Study Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?